SI21137A - Derivati azafenilalanina - Google Patents

Derivati azafenilalanina Download PDF

Info

Publication number
SI21137A
SI21137A SI200200013A SI200200013A SI21137A SI 21137 A SI21137 A SI 21137A SI 200200013 A SI200200013 A SI 200200013A SI 200200013 A SI200200013 A SI 200200013A SI 21137 A SI21137 A SI 21137A
Authority
SI
Slovenia
Prior art keywords
formula
compound
same meaning
alkyl
triphosgene
Prior art date
Application number
SI200200013A
Other languages
English (en)
Slovenian (sl)
Inventor
Uroš Urleb
Aleš Obreza
Mojca Stegnar
Bakija Alenka Trampuš
Original Assignee
LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d.
Univerza V Ljubljani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d., Univerza V Ljubljani filed Critical LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d.
Priority to SI200200013A priority Critical patent/SI21137A/sl
Priority to PCT/IB2003/000403 priority patent/WO2004067522A1/fr
Priority to AU2003205963A priority patent/AU2003205963A1/en
Priority to AT0900103A priority patent/AT503355A2/de
Priority to CH01209/04A priority patent/CH696724A5/de
Priority to DE10392134T priority patent/DE10392134T5/de
Publication of SI21137A publication Critical patent/SI21137A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200200013A 2002-01-24 2002-01-24 Derivati azafenilalanina SI21137A (sl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SI200200013A SI21137A (sl) 2002-01-24 2002-01-24 Derivati azafenilalanina
PCT/IB2003/000403 WO2004067522A1 (fr) 2002-01-24 2003-01-27 Derives d'azaphenylalanine et leur utilisation en tant qu'agents antithrombontiques
AU2003205963A AU2003205963A1 (en) 2002-01-24 2003-01-27 Azaphenylalanine derivatives and their use as antithrombotic agents
AT0900103A AT503355A2 (de) 2002-01-24 2003-01-27 Azaphenylalanine derivatives
CH01209/04A CH696724A5 (de) 2002-01-24 2003-01-27 Azaphenylalaninderivate.
DE10392134T DE10392134T5 (de) 2002-01-24 2003-01-27 Azaphenylalaninderivate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200013A SI21137A (sl) 2002-01-24 2002-01-24 Derivati azafenilalanina
PCT/IB2003/000403 WO2004067522A1 (fr) 2002-01-24 2003-01-27 Derives d'azaphenylalanine et leur utilisation en tant qu'agents antithrombontiques

Publications (1)

Publication Number Publication Date
SI21137A true SI21137A (sl) 2003-08-31

Family

ID=39522234

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200200013A SI21137A (sl) 2002-01-24 2002-01-24 Derivati azafenilalanina

Country Status (6)

Country Link
AT (1) AT503355A2 (fr)
AU (1) AU2003205963A1 (fr)
CH (1) CH696724A5 (fr)
DE (1) DE10392134T5 (fr)
SI (1) SI21137A (fr)
WO (1) WO2004067522A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0516106B1 (pt) 2004-10-14 2021-08-24 Wilex Ag Métodos para purificação e preparação de derivados de 3-hidroxiamidinofenilalanina, e para produção de derivados de 3-amidinofenilalanina
DE102004057195A1 (de) 2004-11-26 2006-06-01 Wilex Ag Kristalline Modifikationen von N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon
GB0523539D0 (en) * 2005-11-18 2005-12-28 Lek Tovarna Farmacevtskih New use of organic compounds
MX2009010071A (es) 2007-04-10 2009-10-16 Bayer Cropscience Ag Derivados de aril isoxazolina insecticidas.
JP7238123B2 (ja) * 2019-06-28 2023-03-13 富士フイルム株式会社 ペプチド化合物の製造方法、保護基形成用試薬、及び、縮合多環芳香族炭化水素化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0511347A1 (fr) * 1990-11-15 1992-11-04 Pentapharm A.G. Derives de la phenylalanine metasubstitues
DE4111394A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
GB9322976D0 (en) * 1993-11-08 1994-01-05 Pfizer Ltd Therapeutic agents
WO2002074756A2 (fr) * 2001-03-21 2002-09-26 Pentapharm Ag Inhibiteurs d'urokinase

Also Published As

Publication number Publication date
WO2004067522A1 (fr) 2004-08-12
CH696724A5 (de) 2007-10-31
DE10392134T5 (de) 2005-10-13
AT503355A2 (de) 2007-09-15
AU2003205963A1 (en) 2004-08-23
AU2003205963A8 (en) 2004-08-23

Similar Documents

Publication Publication Date Title
US6638980B1 (en) Inhibitors of factor Xa
US6545055B1 (en) Inhibitors of factor Xa
DE69829879T2 (de) Indolderivate als faktor xa inhibitoren
US20040067938A1 (en) Quaternary amines and related inhibitors of factor xa
US20020065303A1 (en) Bivalent phenylene inhibitors of factor Xa
US7312235B2 (en) Benzamide inhibitors of factor Xa
US20020058677A1 (en) Isoquinolone inhibitors of factor Xa
US7417144B2 (en) Factor Xa inhibitors
US20020013314A1 (en) 3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa
CZ245994A3 (en) Piperazides of substituted phenylalanine derivatives as thrombin inhibitors
US6777413B2 (en) 2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa
EP1185512A2 (fr) INHIBITEURS DU FACTEUR Xa
US20020052368A1 (en) Oxindole inhibitors of factor Xa
EP0190356B1 (fr) Nouveaux composes d'amidine
EP1311501B1 (fr) Agents antithrombotiques
US9708265B2 (en) Urethanes, ureas, amidines and related inhibitors of factor Xa
SI21137A (sl) Derivati azafenilalanina
AU2004279412A1 (en) Thioether-substituted benzamides as inhibitors of Factor Xa
CA2572735A1 (fr) Nouveaux composes inhibant l'activite du facteur xa
US20020019394A1 (en) Bicyclic sulfonyl amino inhibitors of factor Xa
US20040077690A1 (en) Quaternary amidino based inhibitors of factor xa
SI21097A (sl) Inhibitorji trombina
US7285547B2 (en) Amidinophenylalanine derivatives as thrombin inhibitors
EP0486702A1 (fr) Derive de 4-guanidinobenzoate de phenyle, procede de production dudit derive et inhibiteur de protease contenant ledit derive
JP2004516317A5 (fr)

Legal Events

Date Code Title Description
IF Valid on the prs date
KO00 Lapse of patent

Effective date: 20100901